Who Owns Ozempic? Patent Wars in the World of Weight Loss Drugs

In this segment of “IP in the News” on the Passage to Profit Show we dive into the heated debate over Ozempic, the so-called "miracle" weight loss drug, and the patent battle that could change access to it. With soaring prices and demand for weight loss solutions, drug patents are under scrutiny. Should Novo Nordisk keep exclusive rights, or is it time for competitors to step in and make the drug more affordable? Join us as we discuss the intersection of patents, profits, and public health with insights from experts in pharmaceuticals and fitness.   Richard Gearhart and Elizabeth Gearhart, co-hosts of The Passage to Profit Show along with iHeart Media Maven Kenya Gipson have this discussion with Vince Molinari from Fintech TV, Jesse Ramos from BBT Fitness and Chelsea Chong Kim from Chelsea’s Story Nook.   Whether you're a seasoned entrepreneur, a startup, an inventor, an innovator, a small business or just starting your entrepreneurial journey, tune into Passage to Profit Show for compelling discussions, real-life examples, and expert advice on entrepreneurship, intellectual property, trademarks and more. Visit https://passagetoprofitshow.com/ for the latest updates and episodes.